Suven Life Sciences Limited (NSE:SUVEN)
India flag India · Delayed Price · Currency is INR
278.60
-1.35 (-0.48%)
Nov 11, 2026, 1:40 PM IST

Suven Life Sciences Statistics

Total Valuation

NSE:SUVEN has a market cap or net worth of INR 78.82 billion. The enterprise value is 75.51 billion.

Market Cap78.82B
Enterprise Value 75.51B

Important Dates

The next estimated earnings date is Friday, January 29, 2027.

Earnings Date Jan 29, 2027
Ex-Dividend Date n/a

Share Statistics

Current Share Class 282.56M
Shares Outstanding n/a
Shares Change (YoY) +14.95%
Shares Change (QoQ) +7.59%
Owned by Insiders (%) 0.54%
Owned by Institutions (%) 2.74%
Float 97.26M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 416.84
PB Ratio 17.44
P/TBV Ratio 17.44
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 9.70, with a Debt / Equity ratio of 0.04.

Current Ratio 9.70
Quick Ratio 9.17
Debt / Equity 0.04
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -361.46

Financial Efficiency

Return on equity (ROE) is -103.98% and return on invested capital (ROIC) is -370.70%.

Return on Equity (ROE) -103.98%
Return on Assets (ROA) -58.44%
Return on Invested Capital (ROIC) -370.70%
Return on Capital Employed (ROCE) -84.50%
Weighted Average Cost of Capital (WACC) 9.47%
Revenue Per Employee 1.34M
Profits Per Employee -26.91M
Employee Count142
Asset Turnover 0.04
Inventory Turnover 3.64

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +49.15% in the last 52 weeks. The beta is 0.95, so NSE:SUVEN's price volatility has been similar to the market average.

Beta (5Y) 0.95
52-Week Price Change +49.15%
50-Day Moving Average 311.87
200-Day Moving Average 252.80
Relative Strength Index (RSI) 47.53
Average Volume (20 Days) 610,075

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, NSE:SUVEN had revenue of INR 189.73 million and -3.82 billion in losses. Loss per share was -15.11.

Revenue189.73M
Gross Profit 183.42M
Operating Income -3.95B
Pretax Income -3.82B
Net Income -3.82B
EBITDA -3.88B
EBIT -3.95B
Loss Per Share -15.11
Full Income Statement

Balance Sheet

The company has 3.47 billion in cash and 160.25 million in debt, with a net cash position of 3.31 billion.

Cash & Cash Equivalents 3.47B
Total Debt 160.25M
Net Cash 3.31B
Net Cash Per Share n/a
Equity (Book Value) 4.54B
Book Value Per Share 15.99
Working Capital 3.44B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.20 billion and capital expenditures -488.60 million, giving a free cash flow of -4.69 billion.

Operating Cash Flow -4.20B
Capital Expenditures -488.60M
Depreciation & Amortization 69.78M
Net Borrowing -26.07M
Free Cash Flow -4.69B
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin 96.67%
Operating Margin -2,079.38%
Pretax Margin -2,013.71%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

NSE:SUVEN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -14.95%
Shareholder Yield -14.95%
Earnings Yield -5.42%
FCF Yield -5.93%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 3